Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Carr

Showing results (201-210 of 461) with videos related to

Pageof 47
Sort By:
Digestive Diseases and Sciences|January 27, 2007
Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United StatesBrian I Carr, Futoshi Kanke, Margaret Wise, et al.
Medical Hypotheses|July 4, 2016
A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigmAntonio Mazzocca, Giovanni Ferraro, Giovanni Misciagna, et al.
Cell Biology International|May 11, 2007
Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrixBrian I Carr, Siddhartha Kar, Meifang Wang, et al.
Human Pathology|March 13, 1998
Transforming growth factor alpha (TGFalpha) in hepatocellular carcinomas and adjacent hepatic parenchymaM A Nalesnik, R G Lee, B I Carr
Journal of Gastrointestinal Cancer|October 6, 2021
Relationships Between Indices of Tumor Aggressiveness in Hepatocellular CarcinomaBrian I Carr, Vito Guerra, Rossella Donghia, et al.
The Journal of Rheumatology|June 1, 1975
Comparison of DNA binding in normal population, general hospital laboratory personnel, and personnel from laboratories studying SLER I Carr, A A Hoffmann, R J Harbeck
Annals of Medicine and Surgery (2012)|June 18, 2021
Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomesB I Carr, V Guerra, R Donghia, et al.
Hepatology (Baltimore, Md.)|November 30, 2007
Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5Ziqiu Wang, Lisheng Ge, Meifang Wang, et al.
Hepatology (Baltimore, Md.)|September 1, 1995
The growth inhibitory effects of vitamins K and their actions on gene expressionZ Wang, M Wang, F Finn, et al.
IARC Scientific Publications|January 1, 1984
5-Azacytidine. Promoting activity for rat hepatocellular carcinomaB I Carr, J G Reilly, A D Riggs
Pageof 47

Showing results (201-210 of 461) with videos related to

Sort By:
Pageof 47
Digestive Diseases and Sciences|January 27, 2007
Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin in histologically proven hepatocellular carcinoma in the United StatesBrian I Carr, Futoshi Kanke, Margaret Wise, et al.
Medical Hypotheses|July 4, 2016
A systemic evolutionary approach to cancer: Hepatocarcinogenesis as a paradigmAntonio Mazzocca, Giovanni Ferraro, Giovanni Misciagna, et al.
Cell Biology International|May 11, 2007
Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrixBrian I Carr, Siddhartha Kar, Meifang Wang, et al.
Human Pathology|March 13, 1998
Transforming growth factor alpha (TGFalpha) in hepatocellular carcinomas and adjacent hepatic parenchymaM A Nalesnik, R G Lee, B I Carr
Journal of Gastrointestinal Cancer|October 6, 2021
Relationships Between Indices of Tumor Aggressiveness in Hepatocellular CarcinomaBrian I Carr, Vito Guerra, Rossella Donghia, et al.
The Journal of Rheumatology|June 1, 1975
Comparison of DNA binding in normal population, general hospital laboratory personnel, and personnel from laboratories studying SLER I Carr, A A Hoffmann, R J Harbeck
Annals of Medicine and Surgery (2012)|June 18, 2021
Tumor multifocality and serum albumin levels can identify groups of patients with hepatocellular carcinoma and portal vein thrombosis having distinct survival outcomesB I Carr, V Guerra, R Donghia, et al.
Hepatology (Baltimore, Md.)|November 30, 2007
Grb2-associated binder-1 plays a central role in the hepatocyte growth factor enhancement of hepatoma growth inhibition by K vitamin analog compound 5Ziqiu Wang, Lisheng Ge, Meifang Wang, et al.
Hepatology (Baltimore, Md.)|September 1, 1995
The growth inhibitory effects of vitamins K and their actions on gene expressionZ Wang, M Wang, F Finn, et al.
IARC Scientific Publications|January 1, 1984
5-Azacytidine. Promoting activity for rat hepatocellular carcinomaB I Carr, J G Reilly, A D Riggs
Pageof 47